UNSPSC 51132213: Acetaminophen/caffeine/phenyltoloxamine/salicylamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51132213 Acetaminophen/caffeine/phenyltoloxamine/salicylamide is a Commodity code under which state and local governments procure analgesic and antipyretic combination medications, though recent solicitation activity shows limited direct procurement under this specific code and instead tracks toward broader pharmaceutical supply agreements and emergency-response drug initiatives. The code serves health departments, county health systems, and multistate cooperative purchasing alliances acquiring over-the-counter pain and fever relief products, often as components of larger pharmaceutical or emergency-response inventories rather than standalone line items.

Activity under this code remains sparse. Three recent opportunities illustrate the broader procurement patterns: Seminole County, Florida issued IFB 60459723LAS in June 2026 (due July 26, 2023) for naloxone and drug deactivation systems—a mismatch with the code's scope, signaling that state and local procurement systems sometimes tag emergency pharmaceuticals under unrelated UNSPSC categories. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to explore direct-to-manufacturer prescription programs, also outside the acetaminophen code's nominal scope. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026—the closest match to commodity-level pharmaceutical procurement. This RFP weighted price competitiveness at 75 percent, required cGMP and Drug Supply Chain Security Act compliance, and mandated relationships with authorized wholesalers including AmerisourceBergen, Cardinal Health, and Morris & Dickson. Geographic activity centers on Minnesota and Texas, with scattered Florida procurement. The acetaminophen code shows minimal standalone solicitation activity; buyers typically consolidate OTC pain relievers into multistate cooperative purchasing or emergency-response contracts rather than issuing discrete RFPs for combination analgesics.